Bonus BioGroup Ltd. (TLV:BONS)
Israel
· Delayed Price · Currency is ILS · Price in ILA 21.90
+1.80 (8.96%)
May 13, 2025, 5:24 PM IDT
Bonus BioGroup Market Cap
Bonus BioGroup has a market cap or net worth of 255.78 million as of May 13, 2025. Its market cap has increased by 34.36% in one year.
Market Cap
255.78M
Enterprise Value
259.11M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
21.90
Market Cap Chart
Since July 25, 2012, Bonus BioGroup's market cap has increased from 12.36M to 255.78M, an increase of 1,968.95%. That is a compound annual growth rate of 26.69%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 73.61B |
| Danel (Adir Yeoshua) | 2.35B |
| Kamada | 1.43B |
| Bait Bakfar | 1.15B |
| Novolog (Pharm-Up 1966) | 779.55M |
| SofWave Medical | 722.24M |
| Ilex Medical | 680.80M |
| BrainsWay | 586.43M |